Literature DB >> 25169552

MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ.

Ping Li1, Xiao-Bing Xie, Qian Chen, Guo-Lian Pang, Wan Luo, Jian-Cheng Tu, Fang Zheng, Song-Mei Liu, Lu Han, Jian-Kun Zhang, Xian-Yong Luo, Xin Zhou.   

Abstract

BACKGROUND: Recent studies have indicated that microRNA-15a (miR-15a) is dysregulated in breast cancer (BC). We aimed to evaluate the expression of miR-15a in BC tissues and corresponding para-carcinoma tissues. We also focused on effects of miR-15a on cellular behavior of MDA-MB-231 and expression of its target gene synuclein-γ (SNCG).
MATERIALS AND METHODS: The expression levels of miR-15a were analysed in BC formalin fixed paraffin embedded (FFPE) tissues by microarray and quantitative real-time PCR. CCK-8 assays, cell cycle and apoptosis assays were used to explore the potential functions of miR-15a in MDA-MB-231 human BC cells. A luciferase reporter assay confirmed direct targets.
RESULTS: Downregulation of miR-15a was detected in most primary BCs. Ectopic expression of miR-15a promoted proliferation and suppressed apoptosis in vivo. Further studies indicated that miR-15a may directly interact with the 3'-untranslated region (3'-UTR) of SNCG mRNA, downregulating its mRNA and protein expression levels. SNCG expression was negatively correlated with miR-15a expression.
CONCLUSIONS: MiR-15a has a critical role in mediating cell cycle arrest and promoting cell apoptosis of BC, probably by directly targeting SNCG. Thus, it may be involved in development and progression of BC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25169552     DOI: 10.7314/apjcp.2014.15.16.6949

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

1.  Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.

Authors:  Lu Han; Pei Ma; Song-Mei Liu; Xin Zhou
Journal:  Tumour Biol       Date:  2015-12-10

2.  MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.

Authors:  Christopher Alderman; Ayoub Sehlaoui; Zhaoyang Xiao; Yixin Yang
Journal:  Tumour Biol       Date:  2016-08-04

3.  MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.

Authors:  Peter T Nelson; Wang-Xia Wang; Sarah A Janse; Katherine L Thompson
Journal:  Brain Res       Date:  2017-11-13       Impact factor: 3.252

4.  MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

Authors:  Fei Shen; Wen-Song Cai; Zhe Feng; Jiang-Lin Li; Ji-Wei Chen; Jie Cao; Bo Xu
Journal:  Tumour Biol       Date:  2014-11-19

5.  Downregulation of microRNA-497 is associated with upregulation of synuclein γ in patients with osteosarcoma.

Authors:  Liang Wang; Hongwei Gao; Ningji Gong; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2016-10-26       Impact factor: 2.447

6.  MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway.

Authors:  Tao Liu; Jichao Guo; Xiaoxia Zhang
Journal:  Cancer Biol Ther       Date:  2019-04-14       Impact factor: 4.742

7.  Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Authors:  Zhongqing Li; Lanting Liu; Chenxing Du; Zhen Yu; Yuanyuan Yang; Jie Xu; Xiaojing Wei; Fenghuang Zhan; Yongrong Lai; Lugui Qiu; Mu Hao
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

8.  Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.

Authors:  Gang Li; Tie Chong; Xiaolong Xiang; Jie Yang; Hongliang Li
Journal:  Oncol Rep       Date:  2017-08-11       Impact factor: 3.906

9.  MicroRNA-490 inhibits tumorigenesis and progression in breast cancer.

Authors:  Lin Zhao; Xin-Yu Zheng
Journal:  Onco Targets Ther       Date:  2016-07-22       Impact factor: 4.147

10.  Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208).

Authors:  Abolfazl Akbari; Mohammad Hossein Ghahremani; Gholam Reza Mobini; Mahdi Abastabar; Javad Akhtari; Manzar Bolhassani; Mansour Heidari
Journal:  Iran J Basic Med Sci       Date:  2015-09       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.